On average, the FTSE 100‘s dividend yield, is 3.2% right now. So, it follows that any of the index’s constituent stocks with a higher yield would be more desirable to the income investor, yes? Maybe, maybe not. In my opinion that would be so only if the dividend is sustainable and the stock’s price is not falling fast. If the latter is the case, I may make no net gains or worse, end up with a net loss on the investment.
British American Tobacco’s strengths
It is from this perspective that I am now considering whether or not to buy the tobacco stock British American Tobacco (LSE: BATS). It has a dividend yield of 6.4%, which is far above the FTSE 100 average. It is also above the inflation rate, which is pretty high at 5% right now. This in itself makes the stock worth considering.
Is it sustainable, though? Well, I have no reason to doubt it considering that the company has consistently paid dividends over the years. And going by its outlook for 2022, it is quite likely to continue paying them in the future too. I am basing this on the fact that it expects earnings per share to grow. It also mentions “maintaining growing dividends” elsewhere in its latest update.
Competitive price for the FTSE 100 stock
The next question is, what is the outlook for its share price? The British American Tobacco share price is up some 22% in the past year, which sounds positive. As per its latest results for 2021, its earnings are up from the year before. Also, as I mentioned earlier, it expects them to grow next year too. This could continue to push its share price up, particularly because its market valuation is still cheap. It has a price-to-earnings (P/E) ratio of around 11.7 times, which is lower than that for the FTSE 100 at around 18 times.
The long-term challenge
The one big challenge with tobacco stocks, though, is the long-term future. As the company itself points out in its update, global tobacco industry growth is expected to decline by 2.5% in 2022. It expects its own revenue and earnings to grow, but it is hard not to consider how long it can grow in a shrinking industry. Its tobacco alternatives’ division, called new categories, is growing fast, to be sure. But it is still quite small. Even with a 50%+ growth last year, it is less than 10% of the company’s total revenue. At this rate, it might be decades before this market matures, in my view. And what becomes of British American Tobacco in the interim? I am not sure.
My assessment
Perhaps it is for this reason that the FTSE 100 stock has seen quite a steep decline in share price over the past few years. It is down over 30% in the past five years. Also, it compares unfavourably to its FTSE 100 peer Imperial Brands, which trades at a multiple of sub-6 times. And also has a higher dividend yield of 7.8%. Between the two tobacco stocks, I would much prefer it to British American Tobacco and that is why I bought it. Though I am keeping an look out for further developments in the latter, I am not buying it yet.
